IP Library › Patent Application 11932295
Patent Application
App. No. 11/932,295

METHODS FOR REDUCING NEOVASCULARIZATION OR EDEMA

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/932,295
Abstract

Drug delivery devices for reducing or preventing neovascularization or edema in the eye by implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.

Claims (6)

1 . A drug delivery device comprising an anti-inflammatory steroid and a biodegradable polymer.

2 . The device of claim 1 wherein the steroid is dexamethasone.

3 . The device of claim 2 wherein the biodegradable polymer is a polylactic acid polyglycolic acid (PLGA) copolymer.

4 . The device of claim 3 wherein the device comprises about 60 weight % dexamethasone.

5 . The device of claim 3 , wherein the device is a solid bioerodible implant.

6 . The device of claim 5 , wherein the PLGA is an about 50/50 mixture of glycolic acid monomers and lactic acid monomers.